← Back to headlines
Aethlon Expands Hemopurifier Oncology Trial to Cohort 3
Aethlon Medical announced the expansion of its Hemopurifier oncology trial to Cohort 3, increasing the patient count to between three and six. This advancement marks a significant step in the ongoing clinical development of their cancer treatment.
10 Jun, 23:32 — 10 Jun, 23:32
Sources
Showing 1 of 1 sources
